Skip to content
ClinCalc Pro
Menu
Copper chelator

Trientine

Brand names: Cuprior, Cufence

Trientine is a copper-chelating agent used to treat Wilson's disease, particularly in patients intolerant of penicillamine.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It chelates copper and promotes its urinary excretion, reducing the toxic copper accumulation characteristic of Wilson's disease.

Prescribing in practice

  • Different trientine salt formulations are not interchangeable on a milligram basis and switching requires care, as inadequate treatment risks neurological and hepatic deterioration.
  • It can cause iron deficiency through reduced iron absorption, and any iron supplementation should be separated in time from trientine.
  • It should be taken on an empty stomach away from food, milk and other medicines to preserve absorption; refer to the SPC.

Monitoring

Copper status (such as urinary copper and non-caeruloplasmin copper), full blood count for iron deficiency, and clinical response are monitored regularly.

Counselling the patient

  • Take this medicine on an empty stomach, separated from food and other tablets, exactly as directed.
  • Do not take iron supplements at the same time of day as trientine.
  • Keep taking it continuously, as stopping can cause your condition to worsen.

Evidence & guidelines

Trientine is an established second-line chelator for Wilson's disease supported by long-standing clinical use.

Reference: NICE; SmPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.